3 results
Search Results
2. Multiple mediation analysis with survival outcomes: With an application to explore racial disparity in breast cancer survival.
- Author
-
Yu, Qingzhao, Wu, Xiaocheng, Li, Bin, and Scribner, Richard A.
- Subjects
- *
BREAST tumor treatment , *ALGORITHMS , *BLACK people , *BREAST tumors , *CHAOS theory , *COMPARATIVE studies , *HEALTH services accessibility , *HEALTH status indicators , *RESEARCH methodology , *MEDICAL cooperation , *POPULATION , *REGRESSION analysis , *RESEARCH , *RESEARCH funding , *SURVIVAL analysis (Biometry) , *WHITE people , *SOCIOECONOMIC factors , *EVALUATION research , *TREATMENT effectiveness , *PROPORTIONAL hazards models , *STATISTICAL models - Abstract
Mediation analysis allows the examination of effects of a third variable in the pathway between an exposure and an outcome. The general multiple mediation analysis method, proposed by Yu et al, improves traditional methods (eg, estimation of natural and controlled direct effects) to enable consideration of multiple mediators/confounders simultaneously and the use of linear and nonlinear predictive models for estimating mediation/confounding effects. In this paper, we extend the method for time-to-event outcomes and apply the method to explore the racial disparity in breast cancer survivals. Breast cancer is the most common cancer and the second leading cause of cancer death among women of all races. Despite improvement of survival rates of breast cancer in the US, a significant difference between white and black women remains. Previous studies have found that more advanced and aggressive tumors and less than optimal treatment may explain the lower survival rates for black women as compared to white women. Due to limitations of current analytic methods and the lack of comprehensive data sets, researchers have not been able to differentiate the relative effect each factor contributes to the overall racial disparity. We use the CDC-funded Patterns of Care study to examine the determinants of racial disparities in breast cancer survival using a novel multiple mediation analysis. Using the proposed method, we applied the Cox hazard model and multiple additive regression trees as predictive models and found that all racial disparity in survival among Louisiana breast cancer patients were explained by factors included in the study. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
- Author
-
Wang, Xueying, Zhang, Pengyue, Chiang, Chien‐Wei, Wu, Hengyi, Shen, Li, Ning, Xia, Zeng, Donglin, Wang, Lei, Quinney, Sara K., Feng, Weixing, Li, Lang, and Chiang, Chien-Wei
- Subjects
- *
ALGORITHMS , *BIOLOGICAL models , *COMBINATION drug therapy , *COMPARATIVE studies , *COMPUTER simulation , *DATABASES , *DRUG interactions , *DRUG side effects , *RESEARCH methodology , *MEDICAL cooperation , *MUSCLE diseases , *PROBABILITY theory , *RESEARCH , *RESEARCH funding , *STATISTICS , *DATA mining , *EVALUATION research , *STATISTICAL models - Abstract
Drug-drug interactions (DDIs) are a common cause of adverse drug events (ADEs). The electronic medical record (EMR) database and the FDA's adverse event reporting system (FAERS) database are the major data sources for mining and testing the ADE associated DDI signals. Most DDI data mining methods focus on pair-wise drug interactions, and methods to detect high-dimensional DDIs in medical databases are lacking. In this paper, we propose 2 novel mixture drug-count response models for detecting high-dimensional drug combinations that induce myopathy. The "count" indicates the number of drugs in a combination. One model is called fixed probability mixture drug-count response model with a maximum risk threshold (FMDRM-MRT). The other model is called count-dependent probability mixture drug-count response model with a maximum risk threshold (CMDRM-MRT), in which the mixture probability is count dependent. Compared with the previous mixture drug-count response model (MDRM) developed by our group, these 2 new models show a better likelihood in detecting high-dimensional drug combinatory effects on myopathy. CMDRM-MRT identified and validated (54; 374; 637; 442; 131) 2-way to 6-way drug interactions, respectively, which induce myopathy in both EMR and FAERS databases. We further demonstrate FAERS data capture much higher maximum myopathy risk than EMR data do. The consistency of 2 mixture models' parameters and local false discovery rate estimates are evaluated through statistical simulation studies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.